Real-World Data Confirm Efficacy of Dupilumab in Severe EoE

Dupilumab demonstrated real-world efficacy in patients with severe, treatment-refractory fibrostenotic eosinophilic esophagitis, most of whom would not have qualified for prior clinical trials.

Related Keywords

Christopher Lee ,Evan Dellon ,University Of North Carolina ,Esophageal Diseases ,North Carolina ,Chapel Hill ,Clinical Gastroenterology ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Eosinophilic Esophagitis ,Refractory ,Esophagitis ,Esophagus ,Oesophageal ,Esophagogastroduodenoscopy ,Eosinophils ,Osinophil Granulocytes ,